MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model

被引:0
作者
Hiroki Sakamoto
Koji Miyanishi
Shingo Tanaka
Ryo Ito
Kota Hamaguchi
Akira Sakurada
Masanori Sato
Tomohiro Kubo
Takahiro Osuga
Kazuyuki Murase
Kohichi Takada
Yusaku Nakabeppu
Masayoshi Kobune
Junji Kato
机构
[1] Sapporo Medical University School of Medicine,Department of Medical Oncology
[2] Sapporo Medical University School of Medicine,Department of Hematology
[3] Kyushu University,Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic steatohepatitis (NASH)-related HCC is associated with oxidative stress. However, the mechanisms underlying the development of NASH-related HCC is unclear. MUTYH is one of the enzymes that is involved in repair of oxidative DNA damage. The aim of this study was to investigate the association between MUTYH and NASH-related hepatocarcinogenesis. MUTYH wild-type (Mutyh+/+), heterozygous (Mutyh+/−), and MUTYH-null (Mutyh−/−) mice were fed a high-fat high-cholesterol (HFHC) diet or HFHC + high iron diet (20 mice per group) for 9 months. Five of 20 Mutyh−/− mice fed an HFHC + high iron diet developed liver tumors, and they developed more liver tumors than other groups (especially vs. Mutyh+/+ fed an HFHC diet, P = 0.0168). Immunohistochemical analysis revealed significantly higher accumulation of oxidative stress markers in mice fed an HFHC + high iron diet. The gene expression profiles in the non-tumorous hepatic tissues were compared between wild-type mice that developed no liver tumors and MUTYH-null mice that developed liver tumors. Gene Set Enrichment Analysis identified the involvement of the Wnt/β-catenin signaling pathway and increased expression of c-Myc in MUTYH-null liver. These findings suggest that MUTYH deficiency is associated with hepatocarcinogenesis in patients with NASH with hepatic iron accumulation.
引用
收藏
相关论文
共 45 条
  • [1] Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
  • [2] Yki-Järvinen H(2014)Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Lancet Diabetes Endocrinol. 2 901-910
  • [3] McPherson S(2015)Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management J. Hepatol. 62 1148-1155
  • [4] Ascha MS(2010)The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 1972-1978
  • [5] Toyokuni S(2016)Oxidative stress as an iceberg in carcinogenesis and cancer biology Arch. Biochem. Biophys. 595 46-49
  • [6] Kato J(2001)Normalization of elevated hepatic 8-hydroxy-2-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res. 61 8697-8702
  • [7] Tanaka S(2013)Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma J. Gastroenterol. 48 1249-1258
  • [8] Bugianesi E(2007)Non-alcoholic steatohepatitis and cancer Clin. Liver Dis. 11 191-207
  • [9] Hoki T(2015)Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis Hepatology 62 751-761
  • [10] Nakashima T(2005)Elevation of serum thioredoxin levels in patients with nonalcoholic steatohepatitis Hepatol. Res. 33 135-137